Theranostic Potential of an NAD(P)H‐Activatable Fluorophore: Assessing Cancer Aggressiveness and Triggering Apoptosis
Angewandte Chemie International Edition · 2026
DOI: 10.1002/anie.7968058 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Yujin Cha und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Sookmyung Women's University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Apoptosis, Fluorescent Dyes, NADP, Theranostic Nanomedicine. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korean National Research Foundation (NRF), Korea Research Institute of Bioscience and Biotechnology (KRIBB), National Research Council of Science & Technology (NST).
Abstract (Originalsprache)
Molecular theranostics, integrating precise diagnosis with targeted therapy, represents a cornerstone of personalized medicine. As a pivotal metabolic cofactor, reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H) is intrinsically linked to cancer progression and survival when dysregulated. In this study, we report DE‐CQ , an NAD(P)H‐activatable fluorophore that enables both cancer imaging and apoptosis. DE‐CQ allows the real‐time quantification and visualization of intracellular NAD(P)H, serving as a robust molecular indicator of cancer malignancy. Beyond its diagnostic utility, DE‐CQ preferentially induces mitochondria‐ and ER stress‐dependent, caspase‐mediated apoptosis in aggressive MDA‐MB‐231 cancer cells while maintaining minimal toxicity toward normal cells. Our findings demonstrate that DE‐CQ functions as a potent theranostic agent, simultaneously providing diagnostic insights into cancer aggressiveness and triggering cell death. Given its dual functionality and high selectivity, DE‐CQ holds significant potential as a next‐generation platform for advanced, personalized cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Sookmyung Women's University, Seoul, Republic of Korea.
- Chemical Biology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Cheongju, Republic of Korea.
- College of Pharmacy, Chungbuk National University, Cheongju, Republic of Korea.
- Department of Chemistry, Chung-Ang University, Seoul, Republic of Korea.
- Therapeutics & Biotechnology Division, Korea Research Institute of Chemical Technology (KRICT), Daejeon, South Korea.
- Department of Chemical and Biological Engineering, Sookmyung Women's University, Seoul, Republic of Korea.
ORCID-Profile: Taehoon Oh, Dong-Sik Shin, Sung-Kyun Ko, Min Hee Lee
Förderung
- Korean National Research Foundation (NRF)
- Korea Research Institute of Bioscience and Biotechnology (KRIBB)
- National Research Council of Science & Technology (NST)
Zitieren
APA
Cha, Y., Oh, T., Kim, H. J., Kang, M., Yoon, S. A., Lee, Y., Lee, Y. J., Park, S. Y., Shin, D. S., Ko, S. K., Han, J., & Lee, M. H. (2026). Theranostic Potential of an NAD(P)H‐Activatable Fluorophore: Assessing Cancer Aggressiveness and Triggering Apoptosis. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.7968058
Vancouver
Cha Y, Oh T, Kim HJ, Kang M, Yoon SA, Lee Y, et al. Theranostic Potential of an NAD(P)H‐Activatable Fluorophore: Assessing Cancer Aggressiveness and Triggering Apoptosis. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.7968058
BibTeX
@article{Cha2026,
author = {Cha, Yujin and Oh, Taehoon and Kim, Hui Joo and Kang, Minju and Yoon, Shin A and Lee, Yul and Lee, Yeon-Ju and Park, Sun Young and Shin, Dong-Sik and Ko, Sung-Kyun and Han, Jiyou and Lee, Min Hee},
title = {Theranostic Potential of an NAD(P)H‐Activatable Fluorophore: Assessing Cancer Aggressiveness and Triggering Apoptosis},
journal = {Angewandte Chemie International Edition},
year = {2026},
doi = {10.1002/anie.7968058}
}
EUVIMED